Literature DB >> 20677250

Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography.

Sabrina Doblas1, Ting He, Debbie Saunders, Jamie Pearson, Jessica Hoyle, Nataliya Smith, Megan Lerner, Rheal A Towner.   

Abstract

PURPOSE: To evaluate the added value of non-contrast-enhanced MR angiography (MRA) to conventional MR imaging for a detailed characterization of different rodent glioma models.
MATERIALS AND METHODS: Intracerebral tumor cell implantation and chemical induction methods were implemented to obtain rat C6, 9L/LacZ, F98, RG2, and ethyl-nitrosourea (ENU) -induced glioma models, a human U87 MG tumor model as well as a mouse GL261 glioma model. MR assessments were regularly conducted on a 7 Tesla Bruker BioSpin system. The tumor border sharpness and growth characteristics of each glioma model were assessed from T(2)-weighted images. Neovascularization and vascular alterations inherent to each model were characterized by assessing absolute blood volumes, vessel density, length, and diameter using Mathematica and Amira software.
RESULTS: The 9L/LacZ and ENU gliomas both presented flaws that hinder their use as reliable brain tumor models. C6 gliomas were slightly invasive and induced moderate vascular alterations, whereas GL261 tumors dramatically altered the brain vessels in the glioma region. F98, RG2, and U87 are infiltrative models that produced dramatic vascular alterations.
CONCLUSION: MRI and MRA provided crucial in vivo information to identify a distinctive "fingerprint" for each of our seven rodent glioma models. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20677250      PMCID: PMC2915452          DOI: 10.1002/jmri.22263

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  36 in total

1.  Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas.

Authors:  P E Kish; M Blaivas; M Strawderman; K M Muraszko; D A Ross; B D Ross; G McMahon
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

2.  Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.

Authors:  S Y Cheng; H J Huang; M Nagane; X D Ji; D Wang; C C Shih; W Arap; C M Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.

Authors:  Giles H Vince; Martin Bendszus; Tilmann Schweitzer; Roland H Goldbrunner; Sabine Hildebrandt; Johannes Tilgner; Rüdiger Klein; Laszlo Solymosi; Jörg Christian Tonn; Klaus Roosen
Journal:  Exp Neurol       Date:  2004-12       Impact factor: 5.330

4.  Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice.

Authors:  Fredrik K Johansson; Hanna Göransson; Bengt Westermark
Journal:  Oncogene       Date:  2005-06-02       Impact factor: 9.867

Review 5.  Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.

Authors:  Till Acker; Karl H Plate
Journal:  Cell Tissue Res       Date:  2003-07-29       Impact factor: 5.249

Review 6.  Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.

Authors:  Hiroyasu Yasuda
Journal:  Nitric Oxide       Date:  2008-05-06       Impact factor: 4.427

Review 7.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

8.  Malignancy-associated vessel tortuosity: a computer-assisted, MR angiographic study of choroid plexus carcinoma in genetically engineered mice.

Authors:  E Bullitt; P A Wolthusen; L Brubaker; W Lin; D Zeng; T Van Dyke
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

9.  Synaptophysin expression in "ependymal tumors" induced by ethyl-nitrosourea in rats.

Authors:  J Vaquero; S Coca; M Zurita; S Oya; A Arias; M Moreno; C Morales
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

10.  Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation.

Authors:  Kenneth Hensley; Haitham Abdel-Moaty; Jerrod Hunter; Molina Mhatre; Shenyun Mou; Kim Nguyen; Tamara Potapova; Quentin N Pye; Min Qi; Heather Rice; Charles Stewart; Katharine Stroukoff; Melinda West
Journal:  J Neuroinflammation       Date:  2006-01-25       Impact factor: 8.322

View more
  36 in total

1.  In vivo characterization of several rodent glioma models by 1H MRS.

Authors:  Sabrina Doblas; Ting He; Debra Saunders; Jessica Hoyle; Nataliya Smith; Quentin Pye; Megan Lerner; Randy L Jensen; Rheal A Towner
Journal:  NMR Biomed       Date:  2011-09-23       Impact factor: 4.044

Review 2.  Multiscale imaging and computational modeling of blood flow in the tumor vasculature.

Authors:  Eugene Kim; Spyros Stamatelos; Jana Cebulla; Zaver M Bhujwalla; Aleksander S Popel; Arvind P Pathak
Journal:  Ann Biomed Eng       Date:  2012-05-08       Impact factor: 3.934

3.  Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies.

Authors:  J M Hoxworth; J M Eschbacher; A C Gonzales; K W Singleton; G D Leon; K A Smith; A M Stokes; Y Zhou; G L Mazza; A B Porter; M M Mrugala; R S Zimmerman; B R Bendok; D P Patra; C Krishna; J L Boxerman; L C Baxter; K R Swanson; C C Quarles; K M Schmainda; L S Hu
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-12       Impact factor: 3.825

4.  ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.

Authors:  Jadith Ziegler; Richard Pody; Patricia Coutinho de Souza; Blake Evans; Debra Saunders; Nataliya Smith; Samantha Mallory; Charity Njoku; Yunzhou Dong; Hong Chen; Jiali Dong; Megan Lerner; Osamah Mian; Sai Tummala; James Battiste; Kar-Ming Fung; Jonathan D Wren; Rheal A Towner
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

Review 5.  C6 cell line: the gold standard in glioma research.

Authors:  D Giakoumettis; A Kritis; N Foroglou
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

6.  MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.

Authors:  Kelsie F Timbie; Umara Afzal; Abhijit Date; Clark Zhang; Ji Song; G Wilson Miller; Jung Soo Suk; Justin Hanes; Richard J Price
Journal:  J Control Release       Date:  2017-03-11       Impact factor: 9.776

7.  ELTD1, a potential new biomarker for gliomas.

Authors:  Rheal A Towner; Randy L Jensen; Howard Colman; Brian Vaillant; Nataliya Smith; Rebba Casteel; Debra Saunders; David L Gillespie; Robert Silasi-Mansat; Florea Lupu; Cory B Giles; Jonathan D Wren
Journal:  Neurosurgery       Date:  2013-01       Impact factor: 4.654

8.  Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.

Authors:  Fernando Francisco Borges Resende; Simoneide Souza Titze-de-Almeida; Ricardo Titze-de-Almeida
Journal:  Oncol Lett       Date:  2018-02-01       Impact factor: 2.967

9.  Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas.

Authors:  Antonio Di Ieva; Sabine Göd; Günther Grabner; Fabio Grizzi; Camillo Sherif; Christian Matula; Manfred Tschabitscher; Siegfrid Trattnig
Journal:  Neuroradiology       Date:  2012-08-18       Impact factor: 2.804

10.  MRI assessment of experimental gliomas using 17.6 T.

Authors:  Marc A Schwarz; Mirko Pham; Xavier Helluy; Arnd Doerfler; Tobias Engelhorn
Journal:  Neuroradiology       Date:  2013-03-10       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.